| |
| |
|
| Insider
Information: |
Gollob Jared |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
95,740 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
95,740 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-03-04 |
95,740 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-03-04 |
4 |
S |
$41.41 |
$139,967 |
D/D |
(3,344) |
95,740 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,375 |
99,084 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-27 |
4 |
AS |
$45.00 |
$18,000 |
D/D |
(400) |
74,709 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-27 |
4 |
OE |
$2.08 |
$832 |
D/D |
400 |
75,109 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
AS |
$35.39 |
$1,638,071 |
D/D |
(46,137) |
74,709 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
OE |
$2.08 |
$95,965 |
D/D |
46,137 |
120,846 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-03-02 |
4 |
AS |
$30.88 |
$40,233 |
D/D |
(1,298) |
74,709 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
76,007 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-05-04 |
4 |
OE |
$1.31 |
$33,740 |
D/D |
20,000 |
57,257 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,600 |
37,257 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-11-02 |
4 |
AS |
$62.89 |
$948,063 |
D/D |
(14,996) |
24,657 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-11-02 |
4 |
OE |
$2.08 |
$31,192 |
D/D |
14,996 |
39,653 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-11-01 |
4 |
AS |
$60.40 |
$2,625,595 |
D/D |
(42,497) |
24,657 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-11-01 |
4 |
OE |
$1.31 |
$35,783 |
D/D |
24,607 |
67,154 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-15 |
4 |
AS |
$60.17 |
$620,052 |
D/D |
(10,305) |
42,547 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-15 |
4 |
OE |
$1.31 |
$10,218 |
D/D |
7,800 |
52,852 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-11 |
4 |
AS |
$60.05 |
$281,939 |
D/D |
(4,695) |
45,052 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-11 |
4 |
OE |
$1.31 |
$2,882 |
D/D |
2,200 |
49,747 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-24 |
4 |
AS |
$50.91 |
$441,671 |
D/D |
(8,675) |
47,547 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-23 |
4 |
AS |
$49.65 |
$957,554 |
D/D |
(19,285) |
56,222 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-22 |
4 |
AS |
$52.63 |
$479,130 |
D/D |
(9,104) |
75,507 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-19 |
4 |
AS |
$55.09 |
$489,559 |
D/D |
(8,887) |
84,611 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-18 |
4 |
AS |
$55.94 |
$363,540 |
D/D |
(6,499) |
93,498 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-02-17 |
4 |
AS |
$58.39 |
$440,836 |
D/D |
(7,550) |
99,997 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Medical OfficerOfficer |
• – – |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
107,547 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
